Menveo

Menveo Description

vaccine, meningococcal

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
One dose (0.5 ml of the reconstituted vaccine) contains: (Originally contained in the powder): Meningococcal group A oligosaccharide 10 micrograms; Conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms.
(Originally contained in the solution): Meningococcal group C oligosaccharide 5 micrograms; Conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms.
Meningococcal group W135 oligosaccharide 5 micrograms; Conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms.
Meningococcal group Y oligosaccharide 5 micrograms; Conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms.
The powder is a white to off- white cake.
The solution is a colourless clear solution.
Excipients/Inactive Ingredients: Powder: Sucrose, Potassium dihydrogen phosphate.
Solution: Sodium dihydrogen phosphate monohydrate, Disodium phosphate dihydrate, Sodium chloride, Water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in